To update and integrate the recommendations for ankylosing spondylitis and the
recommendations for the use of tumour necrosis factor inhibitors (TNFi) in axial …

Objectives To update the Assessment of SpondyloArthritis international Society (ASAS)-
EULAR recommendations for the management of axial spondyloarthritis (axSpA). Methods …

Objective To update the evidence of non-biological treatments for axial spondyloarthritis
(axSpA), as a basis for the 2022 Assessment of SpondyloArthritis international Society …

This first update of the ASAS/EULAR recommendations on the management of ankylosing
spondylitis (AS) is based on the original paper, a systematic review of existing …

Objective: To develop evidence based recommendations for the management of ankylosing
spondylitis (AS) as a combined effort of the 'ASsessment in AS'international working group …

To assess the efficacy and safety of non-biological therapies in patients with axial
spondyloarthritis (axSpA) to inform the update of the Assessment of SpondyloArthritis …

Introduction Despite the availability of axial spondyloarthritis (SpA) recommendations
proposed by various rheumatology societies, we considered that a region‐specific guideline …

This paper presents the second update of the Assessment in SpondyloArthritis international
Society (ASAS) consensus statement on the use of anti-tumour necrosis factor (anti-TNF) …

Objective To provide evidence‐based recommendations for the treatment of patients with
ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). Methods A …

Background The current core outcome set for ankylosing spondylitis (AS) has had only
minor adaptations since its development 20 years ago. Considering the significant advances …